Deep Longevity
Hong Kong, Hong Kong
Deep Longevity is a global leader in deep learning for aging research specializing in the development of deep biomarkers of aging using clinical blood tests, transcriptomic, proteomic, epigenetic, microbiome, behavioral, wearable, imaging, and multiple other data types. The company holds exclusive licenses to a comprehensive IP portfolio including both granted and pending patents. The company provides a broad range of deep aging clocks to some of the world's most advanced longevity clinics and physicians and is developing a range of simple consumer applications to track the rate of aging at the individual level. The company is developing a comprehensive decision support system for physicians to enable the development of personalized longevity protocols utilizing the latest advances in longevity biotechnology.
Company Info
- Founded
- 2020
- Website
- deeplongevity.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Deep Longevity?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.